Literature DB >> 20924298

Bone invasion by adenoid cystic carcinoma of the lacrimal gland: preoperative imaging assessment and surgical considerations.

Michelle D Williams1, Nagham Al-Zubidi, J Matthew Debnam, Roman Shinder, Franco DeMonte, Bita Esmaeli.   

Abstract

PURPOSE: To identify the incidence of radiologically and histologically documented bony invasion of the lacrimal gland fossa by adenoid cystic carcinoma. PATIENTS AND METHODS: The authors reviewed the records of all 18 patients with lacrimal gland adenoid cystic carcinoma surgically treated at their institution from 1997 to 2009 for imaging findings (blinded review) and histologic findings on evaluation of the lacrimal gland fossa. Preoperative CT and/or MRI findings were available for 17 patients.
RESULTS: The 8 men and 10 women ranged in age from 9 to 69 years. American Joint Committee on Cancer tumor stages after preoperative imaging were as follows: T1N0M0, 2 patients; T2N0M0, 5 patients; T3aN0M0, 2 patients; T3bN0M0, 5 patients; T3bN0M1, 2 patients; T4bN0M0, one patient; and TxN0M0, one patient. Preoperative imaging suggested bony involvement of the lacrimal gland fossa in 13 patients (76.5%); this was histologically confirmed in 11 of the 13. Preoperative imaging suggested no bone involvement in 4 patients, 3 of whom had bone involvement by histology. Overall, 14 of 17 histologically evaluable cases (82.3%) had invasion of the lacrimal gland fossa. Histologic findings of bone/periosteal involvement led to upstaging of 3 tumors. Metastases developed in 8 of 18 patients and trended with basaloid histology (p = 0.066).
CONCLUSIONS: Adenoid cystic carcinoma of the lacrimal gland is associated with bone invasion in essentially all but the smallest of tumors (T1). This high rate of bone involvement may warrant addressing the bony walls during surgery for adenoid cystic carcinoma of the lacrimal gland.

Entities:  

Mesh:

Year:  2010        PMID: 20924298     DOI: 10.1097/IOP.0b013e3181df6ab9

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  6 in total

1.  Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement.

Authors:  T Y Chen; M G Keeney; A V Chintakuntlawar; D L Knutson; S Kloft-Nelson; P T Greipp; J A Garrity; D R Salomao; J J Garcia
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

2.  Frequency and imaging features of the adjacent osseous changes of salivary gland carcinomas in the head and neck region.

Authors:  Daisuke Horiuchi; Taro Shimono; Hiroyuki Tatekawa; Taro Tsukamoto; Hirotaka Takita; Masahiro Okazaki; Yukio Miki
Journal:  Neuroradiology       Date:  2022-05-07       Impact factor: 2.995

3.  Three-Dimensional Multidetector CT for Anatomic Evaluation of Orbital Tumors.

Authors:  J Matthew Debnam; Rory R Mayer; Bita Esmaeli; Jeffrey S Weinberg; Franco Demonte; Nandita Guha-Thakurta
Journal:  J Ophthalmol       Date:  2013-10-31       Impact factor: 1.909

4.  Fibroblast growth factor receptor 1 (FGFR1) as a therapeutic target in adenoid cystic carcinoma of the lacrimal gland.

Authors:  Ravi Doddapaneni; Wensi Tao; Andrea Naranjo; Neda Nikpoor; David T Tse; Daniel Pelaez
Journal:  Oncotarget       Date:  2019-01-11

5.  Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma.

Authors:  Jie Yang; Chuandi Zhou; Yefei Wang; Xianqun Fan; Renbing Jia
Journal:  BMC Ophthalmol       Date:  2019-06-08       Impact factor: 2.209

6.  Extensive and aggressive growth of adenoid cystic carcinoma in the lacrimal gland.

Authors:  Jonghyun Park; Han Koo Kim; Woo Seob Kim; Tae Hui Bae
Journal:  Arch Craniofac Surg       Date:  2020-04-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.